- Retraction Note
- Open Access
Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer
Hereditary Cancer in Clinical Practice volume 16, Article number: 10 (2018)
- The original article was published in Hereditary Cancer in Clinical Practice 2017 15:20
This article  has been retracted at the request of the authors. Upon re-review of the data, the authors identified coding errors in this study. Due to an error in the SQL query, the conclusions drawn in the article are incorrect. A re-examination of the data shows that there is no association between familial breast cancer and the BRCA2 variant c.68–7 T > A. Another recent study suggests that the variant is not pathogenic . All authors agree to this retraction.
Møller P, et al. The BRCA2 variant c.68-7 T>a is associated with breast cancer. Hered Cancer Clin Pract. 2017;15:20.
Colombo M, et al. The BRCA2 c.68-7T > a variant is not pathogenic: a model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729–41.
About this article
Cite this article
Møller, P., Hovig, E. Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer. Hered Cancer Clin Pract 16, 10 (2018). https://doi.org/10.1186/s13053-018-0093-1